Through the analysis of copy number alteration of PM samples, we found that there were significant deletions in many genomic regions of PM samples, involving many cancer genes and immune related genes (such as B2M, RHOA, IFNE, JAK1/2, etc.). This evidence concerns the gene RHOA and cancer.